These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Homology of the amyloid beta protein precursor in monkey and human supports a primate model for beta amyloidosis in Alzheimer's disease. Podlisny MB; Tolan DR; Selkoe DJ Am J Pathol; 1991 Jun; 138(6):1423-35. PubMed ID: 1905108 [TBL] [Abstract][Full Text] [Related]
5. Molecular biology of the amyloid of Alzheimer's disease. An overview. Inestrosa NC; Soto C Biol Res; 1992; 25(2):63-72. PubMed ID: 1365703 [TBL] [Abstract][Full Text] [Related]
6. Molecular pathogenesis of beta-amyloidosis in Alzheimer's disease and other cerebral amyloidoses. Maury CP Lab Invest; 1995 Jan; 72(1):4-16. PubMed ID: 7837789 [No Abstract] [Full Text] [Related]
12. An update on the amyloid hypothesis. Eckman CB; Eckman EA Neurol Clin; 2007 Aug; 25(3):669-82, vi. PubMed ID: 17659184 [TBL] [Abstract][Full Text] [Related]
13. Amyloidogenesis in Alzheimer's disease: some possible therapeutic opportunities. Gandy S; Greengard P Trends Pharmacol Sci; 1992 Mar; 13(3):108-13. PubMed ID: 1574806 [TBL] [Abstract][Full Text] [Related]
14. Amyloid plaques, neurofibrillary tangles and neuronal loss in brains of transgenic mice overexpressing a C-terminal fragment of human amyloid precursor protein. Kawabata S; Higgins GA; Gordon JW Nature; 1991 Dec; 354(6353):476-8. PubMed ID: 1793460 [TBL] [Abstract][Full Text] [Related]
15. Alzheimer's research moves to mice. Marx J Science; 1991 Jul; 253(5017):266-7. PubMed ID: 1907022 [No Abstract] [Full Text] [Related]
16. Cellular prion protein modulates β-amyloid deposition in aged APP/PS1 transgenic mice. Ordóñez-Gutiérrez L; Torres JM; Gavín R; Antón M; Arroba-Espinosa AI; Espinosa JC; Vergara C; Del Río JA; Wandosell F Neurobiol Aging; 2013 Dec; 34(12):2793-804. PubMed ID: 23831375 [TBL] [Abstract][Full Text] [Related]
17. Geniposide attenuates insulin-deficiency-induced acceleration of β-amyloidosis in an APP/PS1 transgenic model of Alzheimer's disease. Zhang Y; Yin F; Liu J; Liu Z; Guo L; Xia Z; Zidichouski J Neurochem Int; 2015 Oct; 89():7-16. PubMed ID: 25882165 [TBL] [Abstract][Full Text] [Related]
18. Aging, gender and APOE isotype modulate metabolism of Alzheimer's Abeta peptides and F-isoprostanes in the absence of detectable amyloid deposits. Yao J; Petanceska SS; Montine TJ; Holtzman DM; Schmidt SD; Parker CA; Callahan MJ; Lipinski WJ; Bisgaier CL; Turner BA; Nixon RA; Martins RN; Ouimet C; Smith JD; Davies P; Laska E; Ehrlich ME; Walker LC; Mathews PM; Gandy S J Neurochem; 2004 Aug; 90(4):1011-8. PubMed ID: 15287908 [TBL] [Abstract][Full Text] [Related]
19. Cannabinoid receptor 1 deficiency in a mouse model of Alzheimer's disease leads to enhanced cognitive impairment despite of a reduction in amyloid deposition. Stumm C; Hiebel C; Hanstein R; Purrio M; Nagel H; Conrad A; Lutz B; Behl C; Clement AB Neurobiol Aging; 2013 Nov; 34(11):2574-84. PubMed ID: 23838176 [TBL] [Abstract][Full Text] [Related]
20. Lewy bodies in Alzheimer's disease in which the primary lesion is a mutation in the amyloid precursor protein. Hardy J Neurosci Lett; 1994 Oct; 180(2):290-1. PubMed ID: 7700596 [No Abstract] [Full Text] [Related] [Next] [New Search]